443 related articles for article (PubMed ID: 32340618)
1. Imaging biomarkers in neurodegeneration: current and future practices.
Young PNE; Estarellas M; Coomans E; Srikrishna M; Beaumont H; Maass A; Venkataraman AV; Lissaman R; Jiménez D; Betts MJ; McGlinchey E; Berron D; O'Connor A; Fox NC; Pereira JB; Jagust W; Carter SF; Paterson RW; Schöll M
Alzheimers Res Ther; 2020 Apr; 12(1):49. PubMed ID: 32340618
[TBL] [Abstract][Full Text] [Related]
2. Integrated Positron Emission Tomography/Magnetic Resonance Imaging in clinical diagnosis of Alzheimer's disease.
Gao F
Eur J Radiol; 2021 Dec; 145():110017. PubMed ID: 34826792
[TBL] [Abstract][Full Text] [Related]
3. Optimizing Use of Neuroimaging Tools in Evaluation of Prodromal Alzheimer's Disease and Related Disorders.
Raji CA; Torosyan N; Silverman DHS
J Alzheimers Dis; 2020; 77(3):935-947. PubMed ID: 32804147
[TBL] [Abstract][Full Text] [Related]
4. Neuroimaging in Dementia.
Risacher SL; Apostolova LG
Continuum (Minneap Minn); 2023 Feb; 29(1):219-254. PubMed ID: 36795879
[TBL] [Abstract][Full Text] [Related]
5. Cognitive and Brain Profiles Associated with Current Neuroimaging Biomarkers of Preclinical Alzheimer's Disease.
Besson FL; La Joie R; Doeuvre L; Gaubert M; Mézenge F; Egret S; Landeau B; Barré L; Abbas A; Ibazizene M; de La Sayette V; Desgranges B; Eustache F; Chételat G
J Neurosci; 2015 Jul; 35(29):10402-11. PubMed ID: 26203136
[TBL] [Abstract][Full Text] [Related]
6. Neuroimaging and other modalities to assess Alzheimer's disease in Down syndrome.
Neale N; Padilla C; Fonseca LM; Holland T; Zaman S
Neuroimage Clin; 2018; 17():263-271. PubMed ID: 29159043
[TBL] [Abstract][Full Text] [Related]
7. A focus on structural brain imaging in the Alzheimer's disease neuroimaging initiative.
Braskie MN; Thompson PM
Biol Psychiatry; 2014 Apr; 75(7):527-33. PubMed ID: 24367935
[TBL] [Abstract][Full Text] [Related]
8. Amyloid imaging: Past, present and future perspectives.
Villemagne VL
Ageing Res Rev; 2016 Sep; 30():95-106. PubMed ID: 26827784
[TBL] [Abstract][Full Text] [Related]
9. Neuroimaging correlates with neuropathologic schemes in neurodegenerative disease.
Lowe VJ; Lundt ES; Albertson SM; Przybelski SA; Senjem ML; Parisi JE; Kantarci K; Boeve B; Jones DT; Knopman D; Jack CR; Dickson DW; Petersen RC; Murray ME
Alzheimers Dement; 2019 Jul; 15(7):927-939. PubMed ID: 31175025
[TBL] [Abstract][Full Text] [Related]
10. Multiparametric magnetic resonance imaging and positron emission tomography findings in neurodegenerative diseases: Current status and future directions.
Soni N; Ora M; Bathla G; Nagaraj C; Boles Ponto LL; Graham MM; Saini J; Menda Y
Neuroradiol J; 2021 Aug; 34(4):263-288. PubMed ID: 33666110
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance imaging and positron emission tomography in the diagnosis of neurodegenerative dementias.
Del Sole A; Malaspina S; Magenta Biasina A
Funct Neurol; 2016; 31(4):205-215. PubMed ID: 28072381
[TBL] [Abstract][Full Text] [Related]
12. Neuroimaging in Alzheimer's disease: current role in clinical practice and potential future applications.
Ferreira LK; Busatto GF
Clinics (Sao Paulo); 2011; 66 Suppl 1(Suppl 1):19-24. PubMed ID: 21779719
[TBL] [Abstract][Full Text] [Related]
13. Multimodal imaging in Alzheimer's disease: validity and usefulness for early detection.
Teipel S; Drzezga A; Grothe MJ; Barthel H; Chételat G; Schuff N; Skudlarski P; Cavedo E; Frisoni GB; Hoffmann W; Thyrian JR; Fox C; Minoshima S; Sabri O; Fellgiebel A
Lancet Neurol; 2015 Oct; 14(10):1037-53. PubMed ID: 26318837
[TBL] [Abstract][Full Text] [Related]
14. Imaging Techniques in Alzheimer's Disease: A Review of Applications in Early Diagnosis and Longitudinal Monitoring.
van Oostveen WM; de Lange ECM
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672696
[TBL] [Abstract][Full Text] [Related]
15. The use of positron emission tomography/magnetic resonance imaging in dementia: A literature review.
Lorking N; Murray AD; O'Brien JT
Int J Geriatr Psychiatry; 2021 Oct; 36(10):1501-1513. PubMed ID: 34490651
[TBL] [Abstract][Full Text] [Related]
16. Applied multimodal diagnostics in a case of presenile dementia.
Schönecker S; Brendel M; Huber M; Vollmar C; Huppertz HJ; Teipel S; Okamura N; Levin J; Rominger A; Danek A
BMC Neurol; 2016 Aug; 16():131. PubMed ID: 27506761
[TBL] [Abstract][Full Text] [Related]
17. Recent Advances in Imaging of Preclinical, Sporadic, and Autosomal Dominant Alzheimer's Disease.
Buckley RF
Neurotherapeutics; 2021 Apr; 18(2):709-727. PubMed ID: 33782864
[TBL] [Abstract][Full Text] [Related]
18. Neuroimaging and other biomarkers for Alzheimer's disease: the changing landscape of early detection.
Risacher SL; Saykin AJ
Annu Rev Clin Psychol; 2013; 9():621-48. PubMed ID: 23297785
[TBL] [Abstract][Full Text] [Related]
19. Neuroimaging modality fusion in Alzheimer's classification using convolutional neural networks.
Punjabi A; Martersteck A; Wang Y; Parrish TB; Katsaggelos AK;
PLoS One; 2019; 14(12):e0225759. PubMed ID: 31805160
[TBL] [Abstract][Full Text] [Related]
20. Imaging Biomarkers of Neurodegeneration in Alzheimer's Disease: Distinct Contributions of Cortical MRI Atrophy and FDG-PET Hypometabolism.
Benvenutto A; Giusiano B; Koric L; Gueriot C; Didic M; Felician O; Guye M; Guedj E; Ceccaldi M
J Alzheimers Dis; 2018; 65(4):1147-1157. PubMed ID: 30124446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
